Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8429 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.838 |
Intermediate Similarity |
NPD1613 |
Approved |
0.838 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8099 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8028 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7871 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7866 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7815 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7736 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7724 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7721 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7711 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7682 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7682 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7679 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7673 |
Intermediate Similarity |
NPD37 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD4966 |
Approved |
0.764 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7606 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD228 |
Approved |
0.7569 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.755 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7547 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD7228 |
Approved |
0.75 |
Intermediate Similarity |
NPD7054 |
Approved |
0.75 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1511 |
Approved |
0.75 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7467 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7456 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7451 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7436 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7432 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7419 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1512 |
Approved |
0.74 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7386 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7357 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7351 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7349 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7343 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD919 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7324 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7321 |
Intermediate Similarity |
NPD27 |
Approved |
0.7321 |
Intermediate Similarity |
NPD2489 |
Approved |
0.732 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7279 |
Intermediate Similarity |
NPD290 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7267 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7266 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7262 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2677 |
Approved |
0.726 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7256 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7239 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7208 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD3051 |
Approved |
0.72 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7188 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7184 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD2797 |
Approved |
0.716 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7125 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7115 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7091 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7089 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7086 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7075 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7047 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7041
|
Intermediate Similarity |
NPD6959 |
Discontinued |